Wempacli 260mg Injection
Marketer
Wembrace Biopharma Pvt. Ltd.
Salt Composition
Paclitaxel (6mg/ml)
Overview Wempacli 260mg Injection
Oncaspar 260mg injection is a chemotherapy agent indicated for breast, pancreatic, and non-small cell lung cancers. Administered intravenously by a healthcare professional, dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to your prescribed regimen is crucial, as incorrect usage or overdose can lead to severe adverse reactions. Therapeutic benefits may not be apparent for weeks or months; discontinue only under medical supervision. Common side effects include nausea, vomiting, and fatigue; serious side effects may include edema (swelling), alopecia (hair loss), and weight gain. Concomitant medications may be prescribed to mitigate these effects. Report any unusual bruising, bleeding, sore throat, mouth sores, or fever immediately. This medication can suppress blood cell production, increasing infection risk. Regular blood tests monitoring blood counts and liver function are necessary. Prior to treatment, disclose any pre-existing heart, liver, or kidney conditions, or concurrent use of anti-infectives. Inform your physician of all medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; effective contraception for both partners is essential throughout treatment.
Uses of Wempacli 260mg Injection
Cancers affecting the breast, lung (non-small cell type), and pancreas.
Major Benefits of Wempacli 260mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Wempacli 260mg Injection:
- Nausea
- Vomiting
- Weakness
- Low blood platelets
- Rash
- Upper respiratory tract infection
- Urinary tract infection
- Bleeding
- Anemia (low number of red blood cells)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hair loss
- Decreased blood pressure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use Wempacli 260mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Wempacli 260mg Injection works:
Wempacli 260mg Injection is a cancer treatment that disrupts microtubule networks, essential for cancer cell division and proliferation. This disruption inhibits cancer cell growth, ultimately leading to their demise.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Wempacli 260mg Injection use poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
Administering Wempacli 260mg Injection during pregnancy poses a confirmed risk to the fetus. Therefore, its use is contraindicated. Nevertheless, in exceptional, life-threatening circumstances, a physician might deem its prescription necessary if the potential benefits outweigh the inherent dangers. Physician consultation is essential.
Breast feedingUNSAFE
Administration of Wempacli 260mg Injection is contraindicated while breastfeeding due to potential infant toxicity.
DrivingUNSAFE
Wempacli 260mg Injection can induce adverse reactions that might impair driving ability. While driving between Wempacli 260mg Injection treatments isn't inherently prohibited, consider that the medication includes alcohol, and operating a vehicle may therefore be ill-advised.
KidneySAFE IF PRESCRIBED
Wempacli 260mg Injection poses no safety concerns for individuals with kidney impairment; dosage modification is unnecessary. Nevertheless, consultation with a physician is advisable for patients with pre-existing kidney conditions.
LiverCAUTION
Patients with liver impairment should use Wempacli 260mg Injection cautiously, potentially requiring dosage modification. Consult a physician before use. Wempacli 260mg Injection is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Wempacli 260mg Injection :
NA
Facts to Know About Wempacli 260mg Injection
| Label | Value |
|---|---|
| Chemical Type | Taxane-Based Drugs |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Taxanes: Antimicrotubule Agents |
3,018 People bought this recently